About FULPHILA®
Why FULPHILA?
FULPHILA is a man-made form of granulocyte colony-stimulating factor (G-CSF). G-CSF is a substance produced by the body. It stimulates the growth of neutrophils, a type of white blood cell important in the body’s fight against infection.1
It is the first FDA-approved biosimilar for NEULASTA® (pegfilgrastim).1
The FULPHILA syringe is NOT made with Natural Rubber Latex
FULPHILA comes in single-dose prefilled syringes to help ensure proper dosing
What is Febrile Neutropenia?
The occurrence of a fever when you have a serious decline in your neutrophils, a type of white blood cell, is referred to medically as febrile neutropenia. A patient diagnosed with febrile neutropenia, may have a greater risk of infections than normal following chemotherapy.2
Febrile neutropenia is a common complication in patients undergoing anticancer treatments.2
Effects of Chemotherapy on Your Body
How FULPHILA is administered?
FULPHILA is given as an injection under your skin (subcutaneous injection) by a healthcare provider.
Watch the FULPHILA How to Use video below for information on how to prepare and inject a dose of FULPHILA.
It is important that you do not try to give yourself the injection unless you have received training from your healthcare provider.
You can also download the Instructions for Use leaflet from the link below:
Important Things to Know When Starting FULPHILA
Do not take FULPHILA if you have had a serious allergic reaction to pegfilgrastim or filgrastim products.
Before you receive FULPHILA, tell your healthcare provider about all of your medical conditions, including if you:
- have a sickle cell disorder
- have kidney problems
- are pregnant or plan to become pregnant. It is not known if FULPHILA will harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if FULPHILA passes into your breast milk.
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Do not use FULPHILA for a condition for which it was not prescribed.
Do not give FULPHILA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about FULPHILA that is written for health professionals.
You and your caregiver will be shown how to prepare and inject FULPHILA before you use it.
You should not inject a dose of FULPHILA to children weighing less than 45 kg from a FULPHILA prefilled syringe. A dose less than 0.6 mL (6 mg) cannot be accurately measured using the FULPHILA prefilled syringe.
If you are receiving FULPHILA because you are also receiving chemotherapy, the last dose of FULPHILA should be injected at least 14 days before and 24 hours after your dose of chemotherapy.
Miss a Dose?
If you miss a dose of FULPHILA, talk to your healthcare provider about when you should take your next dose.
How Should You Store FULPHILA?
Keep the FULPHILA prefilled syringe out of the reach of children.
Store FULPHILA in the refrigerator between 36°F to 46°F (2°C to 8°C).
Do not freeze. If FULPHILA is accidentally frozen, allow the prefilled syringe to thaw in the refrigerator before injecting.
Do not use a FULPHILA prefilled syringe that has been frozen more than 1 time. Use a new FULPHILA prefilled syringe.
Keep the prefilled syringe in the original carton to protect from light or physical damage.
Do not shake the prefilled syringe.
Take FULPHILA out of the refrigerator 30 minutes before use and allow it to reach room temperature before preparing an injection.
Throw away (dispose of) any FULPHILA that has been left at room temperature, 68°F to 77ºF (20°C to 25ºC) for more than 72 hours or frozen more than 1 time.
